Old Web
English
Sign In
Acemap
>
authorDetail
>
Aisaku Yamamoto
Aisaku Yamamoto
Medicine
Endothelial stem cell
Sensitization
Pathology
Tyrosine-kinase inhibitor
2
Papers
10
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Efficacy and safety of topical OPA‐15406, a new phosphodiesterase 4 inhibitor, in Japanese patients with atopic dermatitis for 8 weeks: A phase 2, randomized, double‐blind, placebo‐controlled study
2019
Journal of Dermatology
Hidehisa Saeki
Makoto Kawashima
Satoko Sugaya
Kazuhide Oshiden
Hidetsugu Tsubouchi
Takashi Onozuka
Yoshimasa Takahashi
Hideyasu Takata
Nobuko Yoshihara
Kazutomo Toyofuku
Hiroto Kitahara
Tatsuya Izumi
Toshitatsu Nogita
Aisaku Yamamoto
Ichiro Nakasu
Akihiro Kume
Akihiro Sasase
Masako Watanabe
Ken Houki
Show All
Source
Cite
Save
Citations (7)
Vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK 222584 inhibits both the induction and elicitation phases of contact hypersensitivity.
2007
Journal of Dermatology
Aisaku Yamamoto
Hideaki Watanabe
Hirohiko Sueki
Takako Nakanishi
Hajime Yasuhara
Masafumi Iijima
Show All
Source
Cite
Save
Citations (3)
1
map